Role of clinical evaluation committees in sepsis trials: from 'valid cohort' assessment to subgroup analysis.

about

Transfusion of Red Blood Cells to Patients with Sepsis.

P2860

Q40053936-C617A3CE-E963-47F9-9418-9F2EE54F2B9C

P2860

Role of clinical evaluation committees in sepsis trials: from 'valid cohort' assessment to subgroup analysis.

Item

http://www.wikidata.org/entity/Q39979975

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Role of clinical evaluation co ...... sessment to subgroup analysis.

@en

Role of clinical evaluation co ...... sessment to subgroup analysis.

@nl

type

Item

label

Role of clinical evaluation co ...... sessment to subgroup analysis.

@en

Role of clinical evaluation co ...... sessment to subgroup analysis.

@nl

prefLabel

Role of clinical evaluation co ...... sessment to subgroup analysis.

@en

Role of clinical evaluation co ...... sessment to subgroup analysis.

@nl

P1476

Role of clinical evaluation co ...... sessment to subgroup analysis.

@en

P2093

Jean-François Dhainaut

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of recombinant human activated protein C for severe sepsis

Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study.

Clinical trials for severe sepsis. Past failures, and future hopes.

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia

International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee.

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

P2888

cc7686

P304

124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC7686

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24424275

http://www.w3.org/2001/XMLSchema#string

P6179

1029018605

http://www.w3.org/2001/XMLSchema#string

P698

19439041

http://www.w3.org/2001/XMLSchema#string

P921

sepsis

P932

2689452

http://www.w3.org/2001/XMLSchema#string

Role of clinical evaluation committees in sepsis trials: from 'valid cohort' assessment to subgroup analysis.

about

P2860

P2860

Role of clinical evaluation committees in sepsis trials: from 'valid cohort' assessment to subgroup analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P932